Essex Financial Services’s Biogen BIIB Stock Holding History

Essex Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-613	Closed	-$212K	–	464
2021 Q2	$212K	Buy	+613	New	+$186K	0.03%	423

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Essex Financial Services's BIIB Position: Q3 2021 in Review

Essex Financial Services sold out of Biogen (BIIB) in Q3 2021, closing a stake of 613 shares — an estimated $212K sold.

Essex Financial Services first reported a position in BIIB in Q2 2021 and held it in 1 quarter. The position peaked at $212K in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Essex Financial Services reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Essex Financial Services sold 613 Biogen shares in Q3 2021, an estimated $212K.
Essex Financial Services first reported a position in Biogen in Q2 2021 and held it in 1 quarter.
Essex Financial Services's Biogen position peaked at $212K in Q2 2021.
1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Essex Financial Services's 13F filing for Q3 2021, filed 10 Nov 2021.